1.
Expanded 2026 ADA Guidance on SGLT2i in CKD Starting at eGFR ≥20 and combining with a nonsteroidal MRA. d [Internet]. 2026 Jul. 7 [cited 2026 Jul. 28];4(17):34-5. Available from: https://thediabzen.com/index.php/d/article/view/60